HISA的230M计划因未能减少马匹死亡、削减兴奋剂或确保透明度而面临审查。 HISA's $230M program faces scrutiny for failing to reduce horse deaths, cut doping, or ensure transparency.

ARCI的独立评估质疑HISA近2.3亿美元的成本是否合理,指出到2025年年中,黄昏死亡率几乎保持不变,一直保持在99.9%左右。 An independent assessment by the ARCI questions whether HISA’s nearly $230 million cost is justified, noting equine fatality rates have remained nearly unchanged at around 99.9% through mid-2025. 抗兴奋剂试验在2022年至2024年期间下降了46%,尽管种族减少,但没有发现新的兴奋剂。 Anti-doping tests dropped 46% from 2022 to 2024 despite fewer races, and no new doping agents have been found. TCO2测试急剧上升,占测试量的31%,但只有4%的不良结果。 TCO2 testing rose sharply, making up 31% of tests but only 4% of adverse findings. 存在统一规则,但对兽医和地点报告的遵守情况不一致。 Uniform rules exist, but compliance with vet and location reporting is inconsistent. HISA的AI系统缺乏透明度,该机构的运作没有公共记录或公开会议。 HISA’s AI system lacks transparency, and the agency operates without public records or open meetings. ARCI总统马丁(Ed Martin)批评HISA在没有国会审查的情况下仓促创建, 指责成本、诉讼和产业分工不断上涨, 并呼吁改革或更换。 ARCI President Ed Martin criticized HISA’s rushed creation without congressional review, citing rising costs, litigation, and industry division, and called for reform or replacement.